全文获取类型
收费全文 | 468篇 |
免费 | 37篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 30篇 |
妇产科学 | 4篇 |
基础医学 | 40篇 |
口腔科学 | 5篇 |
临床医学 | 72篇 |
内科学 | 96篇 |
皮肤病学 | 7篇 |
神经病学 | 32篇 |
特种医学 | 84篇 |
外科学 | 41篇 |
综合类 | 10篇 |
预防医学 | 20篇 |
眼科学 | 1篇 |
药学 | 16篇 |
肿瘤学 | 59篇 |
出版年
2022年 | 2篇 |
2021年 | 8篇 |
2018年 | 4篇 |
2017年 | 6篇 |
2016年 | 8篇 |
2015年 | 7篇 |
2014年 | 20篇 |
2013年 | 14篇 |
2012年 | 10篇 |
2011年 | 6篇 |
2010年 | 25篇 |
2009年 | 13篇 |
2008年 | 16篇 |
2007年 | 22篇 |
2006年 | 15篇 |
2005年 | 12篇 |
2004年 | 9篇 |
2003年 | 15篇 |
2002年 | 5篇 |
2001年 | 6篇 |
2000年 | 12篇 |
1999年 | 14篇 |
1998年 | 26篇 |
1997年 | 24篇 |
1996年 | 26篇 |
1995年 | 25篇 |
1994年 | 16篇 |
1993年 | 12篇 |
1992年 | 10篇 |
1991年 | 7篇 |
1990年 | 8篇 |
1989年 | 15篇 |
1988年 | 11篇 |
1987年 | 14篇 |
1986年 | 12篇 |
1985年 | 14篇 |
1984年 | 5篇 |
1983年 | 6篇 |
1982年 | 6篇 |
1981年 | 2篇 |
1980年 | 6篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1976年 | 4篇 |
1975年 | 2篇 |
1929年 | 1篇 |
1925年 | 1篇 |
1915年 | 1篇 |
1912年 | 1篇 |
1903年 | 1篇 |
排序方式: 共有518条查询结果,搜索用时 15 毫秒
1.
Imipenem/cilastatin therapy of infections in cancer patients 总被引:2,自引:0,他引:2
Imipenem/cilastatin was administered during 153 febrile episodes occurring in cancer patients and the response rate was 68%. Considering only documented infections the response rate was 71%. Patients who received imipenem as initial therapy had a higher response rate than patients who received it after failing other antibiotics (77% versus 68%). The overall response rates for septicemias and pneumonias were 75% and 58%. Among the 57 gram-negative infections 77% responded, but the response rate was substantially higher if imipenem was used as initial therapy (94% versus 69%). The poorest response rate was observed when imipenem was given as secondary therapy for Pseudomonas infections (50%), but most of these patients had failed to respond to other appropriate antibiotics. The only serious side effect was seizures which occurred in ten patients, although eight of them had other predisposing factors. Imipenem appears to be a useful antibiotic for treatment of infections, even in neutropenic cancer patients. 相似文献
2.
3.
Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: involvement of IFN-gamma 总被引:1,自引:0,他引:1
Hsu SC; Obeid OE; Collins M; Iqbal M; Chargelegue D; Steward MW 《International immunology》1998,10(10):1441-1447
Plasmid DNA vectors have been constructed with minigenes encoding a single
cytotoxic T lymphocyte (CTL) epitope from either the M2 protein of
respiratory syncytial virus (RSV) or from the nucleoprotein of measles
virus (MV) with or without a signal sequence (also called secretory or
leader sequence). Following intradermal immunization, plasmids in which the
CTL epitopes were expressed in-frame with the signal sequence were more
effective at inducing peptide- and virus- specific CTL responses than
plasmids expressing CTL epitopes without the signal sequence. This
immunization resulted in protection against MV-induced encephalitis and a
significant reduction in viral load following RSV challenge. The reduction
of viral load following RSV challenge was abrogated by prior injection with
anti-IFN-gamma antibodies. These results highlight the ability of
epitope-based DNA immunization to induce protective immune responses to
well-defined epitopes and indicate the potential of this approach for the
development of vaccines against infectious diseases.
相似文献
4.
5.
MW Lieberman R Barrios G Kala SV Kala ED Lykissa CN Ou 《Environmental health perspectives》1999,107(9):A444-A445
Respond on comments on Lieberman's article: Cyclosiloxanes Produce Fatal Liver and Lung Damage in Mice. Environ Health Perspect 107:161-165 相似文献
6.
Elting LS Escalante CP Cooksley C Avritscher EB Kurtin D Hamblin L Khosla SG Rivera E 《Archives of internal medicine》2004,164(15):1653-1661
BACKGROUND: Although deep venous thrombosis (DVT) often complicates the clinical course in patients with cancer, few studies of the outcomes of DVT in this population have been published. Furthermore, the cost of DVT is largely undescribed. We herein report the largest study of DVT in this population to date. METHODS: We reviewed the medical records of 529 consecutive cancer patients in whom DVT developed from January 1, 1994, through December 31, 1997, and followed up these patients through December 31, 2000, for outcomes. The cost of hospitalization was obtained from our hospital's cost-accounting system and inflated to 2002 US dollars using the Consumer Price Index for Medical Care. Logistic regression was used to identify factors that were associated with a high risk of poor outcomes. RESULTS: The most common complication of DVT was bleeding, which occurred in 13% of patients. Pulmonary embolus occurred in 4%. Five patients (1%) died of complications of DVT and 5 (1%) of complications of anticoagulation. Recurrence of DVT was common (17% overall), particularly among those who had inferior vena cava filters (32%; P<.001) or a previous episode of DVT (P =.03). All but 4 patients were hospitalized for initial anticoagulation therapy, for a mean of 11 days. The mean cost of hospitalization was 2002 US $20 065. CONCLUSIONS: Among patients with cancer, DVT frequently is associated with serious clinical outcomes. Its treatment is resource intensive and costly. More effective agents and less costly management strategies could have a significant impact on the outcomes and cost of DVT in this population. 相似文献
7.
8.
Martje E. van Egmond MD Corien C. Verschuuren‐Bemelmans MD Esther A. Nibbeling MSc Jan Willem J. Elting MD PhD Deborah A. Sival MD PhD Oebele F. Brouwer MD PhD Jeroen J. de Vries MD Hubertus P. Kremer MD PhD Richard J. Sinke PhD Marina A. Tijssen MD PhD Tom J. de Koning MD PhD 《Movement disorders》2014,29(1):139-143
9.
The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells 总被引:5,自引:0,他引:5
Interferons (IFNs) have been shown to have significant effects on hematopoietic cell growth. Previous studies defining these effects have utilized mouse and human alpha-, beta-, and gamma-IFN isolated from supernatants of stimulated cells. Despite purification, the possible presence of other lymphokines and soluble factors remains a concern. In this study, the effects of gene-cloned alpha- and gamma-IFN on colony- forming units of granulocyte/macrophage (CFU-GM) progenitors cultured from the peripheral blood of normal volunteers were examined. In addition, blast cell colonies from one patient with acute myelogenous leukemia (AML) were studied. The growth of normal CFU-GM and AML blast cell colonies was inhibited in a dose-dependent manner by gamma- and alpha-IFN. gamma-IFN was ten to 100 times more potent than alpha-IFN in that this species of IFN reduced colony formation by greater than 50% at concentrations of less than 15 antiviral U/mL. The effects of gamma- IFN were neutralized by a monoclonal antibody specific for gamma-IFN. These in vitro studies indicate that human gamma-IFN may be an important modulator of myelopoiesis. Although these data indicate a possible efficacy of gamma-IFN in the treatment of AML, the in vitro results should be considered for their in vivo significance. 相似文献
10.